IRWD FY 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$298M+8.9% YoY

Gross Profit

$279M93.5% margin

Operating Income

-$77M-25.9% margin

Net Income

-$117M-39.2% margin

EPS (Diluted)

$-0.78

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$104M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$606M

Total Liabilities

$596M

Stockholders' Equity

$10M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$298M	$274M	+8.9%
Gross Profit	$279M	$272M	+2.5%
Operating Income	-$77M	-$52M	-49.2%
Net Income	-$117M	-$82M	-43.1%